Related Experiment Video

Updated: Oct 15, 2025

Author Spotlight: Exploring the Relationship Between Lipotoxicity and HFpEF
03:42

Author Spotlight: Exploring the Relationship Between Lipotoxicity and HFpEF

Published on: March 29, 2024

1.7K

The relationship between fetuin-A and coronary atherosclerotic heart disease (CHD) and CHD-related risk factors: A

Jianping Zheng1, Maozhi Huang, Qilei Huang

  • 1The First Hospital of Nanping City, No. 317 Zhongshan Road, Nanping City, Fujian Province, PR China.

Medicine
|October 29, 2021
PubMed

Insights

Serum fetuin-A levels are associated with an increased risk of coronary atherosclerotic heart disease (CHD). This protein also shows a significant correlation with age in patients with CHD.

Area of Science:

  • Cardiovascular Research
  • Biochemistry
  • Medical Diagnostics

Background:

  • Fetuin-A is recognized for its roles in antivascular calcification and inflammatory processes.
  • Understanding the link between fetuin-A and coronary atherosclerotic heart disease (CHD) is crucial for risk assessment.

Purpose of the Study:

  • To investigate the association between serum fetuin-A levels and the risk of developing CHD.
  • To explore the relationship between fetuin-A and established CHD risk factors.

Main Methods:

  • Enzyme-linked immunosorbent assay (ELISA) was used to measure fetuin-A levels.
  • A comparative study design included 92 CHD patients and 60 healthy controls.
  • Logistic regression analysis identified factors influencing CHD onset.

Main Results:

  • CHD patients exhibited significantly higher levels of fetuin-A, age, male proportion, hypertension, and diabetes compared to controls.
  • High-density lipoprotein cholesterol levels were significantly lower in the CHD group.
  • Fetuin-A levels correlated significantly with age.

Conclusions:

  • Serum fetuin-A is linked to the onset risk of coronary atherosclerotic heart disease.
  • Age is a significant factor associated with fetuin-A levels in the context of CHD.

More Related Videos

Author Spotlight: Exploring the Relationship Between Lipotoxicity and HFpEF07:05

Author Spotlight: Exploring the Relationship Between Lipotoxicity and HFpEF

Published on: February 23, 2024

3.4K
Quantification of Atherosclerotic Plaque Activity and Vascular Inflammation using [18-F] Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography FDG-PET/CT10:02

Quantification of Atherosclerotic Plaque Activity and Vascular Inflammation using [18-F] Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography FDG-PET/CT

Published on: May 2, 2012

18.5K

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
483
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
81
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
393
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
177
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
63